Personalised therapeutic management of epileptic patients guided by pathway-driven breath metabolomics.

Kapil Dev SinghMartin OsswaldVictoria C ZiesenitzMo AwchiJakob UsemannLukas L ImbachMalcolm KohlerDiego García-GómezJohannes van den AnkerUrs FreyAlexandre N DattaPablo M-L Sinues

Published in: Communications medicine (2021)

These results show that real-time breath analysis of epileptic patients provides reliable estimations of systemic drug concentrations along with risk estimates for drug response and side effects.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
mass spectrometry
patient reported outcomes
drug induced
adverse drug
electronic health record